We are live on ! Find out more
SIC

Starr International Company Portfolio holdings

AUM $19.9M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+35.77%
1 Year Est. Return
-39.69%
3 Year Est. Return
-26.08%
5 Year Est. Return
-43.79%
10 Year Est. Return
-39.24%
AUM
$39.6M
AUM Growth
+$8.55M
Cap. Flow
+$141K
Cap. Flow %
0.36%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
BCSF icon
Bain Capital Specialty
BCSF
+$141K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 62.13%
2 Financials 37.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$15.7M 39.75%
67,000
BCSF icon
2
Bain Capital Specialty
BCSF
$802M
$12M 30.32%
784,890
+8,964
+1% +$141K
AZN icon
3
AstraZeneca
AZN
$263B
$5.57M 14.07%
46,500
JNJ icon
4
Johnson & Johnson
JNJ
$635B
$3.29M 8.32%
20,000
AIG icon
5
American International
AIG
$41.9B
$2.99M 7.55%
62,788

Similar funds

Starr International Company's Q2 2021 Portfolio in Review

As of Q2 2021, Starr International Company held 5 positions worth $39.6M, up 28% from $31.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 0%. Starr International Company opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 54% a quarter earlier, followed by Financials.

  • Starr International Company added most to Bain Capital Specialty in Q2 2021, an estimated $141K increase.
  • Starr International Company's ten largest holdings make up 100% of its $39.6M portfolio in Q2 2021.
  • Starr International Company opened 0 new positions and closed 0 in Q2 2021.
  • Starr International Company's portfolio value rose 28% quarter-over-quarter to $39.6M.

Based on Starr International Company's 13F filing for Q2 2021, filed 19 Jul 2021.